Abstract

Background IgG4-related disease is a new disease entity, but little attention was drawn to urinary system involvement besides nephritis or nephropathy. Here, we described clinical, radiological, and pathological manifestations of IgG4-related urinary disease (IgG4-RUD) and assess its treatment responses. Methods We conducted a retrospective study enrolling 65 IgG4-RUD patients from an IgG4-related disease (IgG4-RD) cohort of the Peking Union Medical College Hospital. Clinical, laboratory, radiological, pathological data were collected, and treatment response to immunosuppressants were analysed. Results IgG4-related interstitial nephritis (TIN, 32.3%), glomerular nephritis (GN, 7.7%), renal pelvis and ureter involvement (21.5%), abnormal radiology with quiescent clinical presentation (13.8%), and renal parenchymal lesion plus retroperitoneal fibrosis (RPF, 18.5%) were major lesion types of IgG4-RUD. All patients had elevated serum IgG4, 76.9% had hyperglobulinemia, and 92.3% had elevated serum IgE at diagnosis. IgG4-TIN patients presented with renal dysfunction, and 94.3% had low serum complement C3 and IgG4-GN presented with nephrotic syndrome, while renal pelvis and ureter involvement had normal renal function and urinalysis. IgG4-RPF with renal parenchymal involvement presented with acute renal dysfunction and required emergency medical intervention. Renal cortex low-density areas, parenchyma or pelvis nodular mass, bilateral enlargement of the kidney, and renal pelvis and ureter mass/wall thickening were specific image patterns of IgG4-RUD. Infiltration of plasma lymphocytes and storiform fibrosis were histopathological features of IgG4-RUD. Patients showed satisfactory responses to immunosuppressive treatment, but complete recovery of renal function was difficult to achieve in IgG4-TIN. Four patients (6.2%) experienced clinical relapses during the maintenance period. Conclusion IgG4-RUD had diverse lesion types and distinctive manifestations. Radiological examinations were helpful for diagnosis and treatment evaluation. Patients showed good initial response to immunosuppressive treatment but relapses could occur at the maintenance period.

Highlights

  • IgG4-related disease (IgG4-RD) is an increasingly known systemic clinicopathological entity that is characterized by elevated serum IgG4 levels, tumescent enlargement of multiple organs, diffuse infiltration of plasma lymphocytes, and storiform fibrosis in lesioned organs

  • While pancreas and exocrine gland involvement in IgG4-RD is under the spotlight, few systematic studies focus on urinary system involvement, which accounts for an important proportion of IgG4-RD [4,5,6,7,8]

  • Recent studies have mainly focused on renal parenchymal lesions and retroperitoneal fibrosis (RPF), while little attention has been paid to renal pelvis, ureter, or bladder lesions

Read more

Summary

Introduction

IgG4-related disease (IgG4-RD) is an increasingly known systemic clinicopathological entity that is characterized by elevated serum IgG4 levels, tumescent enlargement of multiple organs, diffuse infiltration of plasma lymphocytes, and storiform fibrosis in lesioned organs. In addition to IgG4-RKD, the renal pelvis, ureter, and bladder were reported as lesion locations in the urinary system of IgG4-RD [13,14,15,16,17]. Recent studies have mainly focused on renal parenchymal lesions and retroperitoneal fibrosis (RPF), while little attention has been paid to renal pelvis, ureter, or bladder lesions. We described clinical, radiological, and pathological manifestations of IgG4-related urinary disease (IgG4-RUD) and assess its treatment responses. IgG4related interstitial nephritis (TIN, 32.3%), glomerular nephritis (GN, 7.7%), renal pelvis and ureter involvement (21.5%), abnormal radiology with quiescent clinical presentation (13.8%), and renal parenchymal lesion plus retroperitoneal fibrosis (RPF, 18.5%) were major lesion types of IgG4-RUD. Patients showed satisfactory responses to immunosuppressive treatment, but complete recovery of renal function was difficult to achieve in IgG4-TIN. Patients showed good initial response to immunosuppressive treatment but relapses could occur at the maintenance period

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call